-
1
-
-
0033052777
-
Mechanisms of action of and resistance to antitubulin agents: Microtubule dynamics, drug transport, and cell death
-
Dumontet C, Sikic BI (1999) Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. J Clin Oncol 17:1061-1070 (Pubitemid 29109340)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.3
, pp. 1061-1070
-
-
Dumontet, C.1
Sikic, B.I.2
-
2
-
-
4744366279
-
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
-
DOI 10.1056/NEJMoa040720
-
Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Theodore C, James ND, Turesson I et al (2004) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351:1502-1512 (Pubitemid 39315317)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.15
, pp. 1502-1512
-
-
Tannock, I.F.1
De Wit, R.2
Berry, W.R.3
Horti, J.4
Pluzanska, A.5
Chi, K.N.6
Oudard, S.7
Theodore, C.8
James, N.D.9
Turesson, I.10
Rosenthal, M.A.11
Eisenberger, M.A.12
-
4
-
-
0027093080
-
Natural products which interact with tubulin in the vinca domain: Maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B
-
DOI 10.1016/0163-7258(92)90028-X
-
Hamel e (1992) Natural products which interact with tubulin in the vinca domain maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B. Pharmacol Ther 55:31-51 (Pubitemid 23018631)
-
(1992)
Pharmacology and Therapeutics
, vol.55
, Issue.1
, pp. 31-51
-
-
Hamel, E.1
-
5
-
-
18744399859
-
Improving the targeting of tubulin-binding agents: Lessons from drug resistance studies
-
DOI 10.2174/1381612053764706
-
Verrills NM, Kavallaris M (2005) Improving the targeting of tubulin-binding agents: lessons from drug resistance studies. Curr Pharm des 11:1719-1733 (Pubitemid 40668146)
-
(2005)
Current Pharmaceutical Design
, vol.11
, Issue.13
, pp. 1719-1733
-
-
Verrills, N.M.1
Kavallaris, M.2
-
6
-
-
69449088145
-
Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs
-
Sanchez C, Mendoza P, Contreras HR, Vergara J, McCubrey JA, Huidobro C, Castellon EA (2009) Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs. Prostate 69:1448-1459
-
(2009)
Prostate
, vol.69
, pp. 1448-1459
-
-
Sanchez, C.1
Mendoza, P.2
Contreras, H.R.3
Vergara, J.4
McCubrey, J.A.5
Huidobro, C.6
Castellon, E.A.7
-
7
-
-
0141888537
-
The role of ABC transporters in clinical practice
-
DOI 10.1634/theoncologist.8-5-411
-
Leonard GD, Fojo T, Bates SE (2003) The role of ABC transporters in clinical practice. Oncologist 8:411-424 (Pubitemid 37238869)
-
(2003)
Oncologist
, vol.8
, Issue.5
, pp. 411-424
-
-
Leonard, G.D.1
Fojo, T.2
Bates, S.E.3
-
8
-
-
0034939512
-
The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: Curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice
-
DOI 10.1073/pnas.131153098
-
Chou TC, O'Connor OA, Tong WP, Guan Y, Zhang ZG, Stachel SJ, Lee C, Danishefsky SJ (2001) The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice. Proc Natl Acad Sci USA 98:8113-8118 (Pubitemid 32642695)
-
(2001)
Proceedings of the National Academy of Sciences of the United States of America
, vol.98
, Issue.14
, pp. 8113-8118
-
-
Chou, T.-C.1
O'Connor, O.A.2
Tong, W.P.3
Guan, Y.4
Zhang, Z.-G.5
Stachel, S.J.6
Lee, C.7
Danishefsky, S.J.8
-
9
-
-
19944428071
-
Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivo
-
DOI 10.1182/blood-2004-06-2499
-
Lin B, Catley L, LeBlanc R, Mitsiades C, Burger R, Tai YT, Podar K, Wartmann M, Chauhan D, Griffin JD, Anderson KC (2005) Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivo. Blood 105:350-357 (Pubitemid 40053103)
-
(2005)
Blood
, vol.105
, Issue.1
, pp. 350-357
-
-
Lin, B.1
Catley, L.2
LeBlanc, R.3
Mitsiades, C.4
Burger, R.5
Tai, Y.-T.6
Podar, K.7
Wartmann, M.8
Chauhan, D.9
Griffin, J.D.10
Anderson, K.C.11
-
10
-
-
0034895987
-
BMS-247550: A novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy
-
Lee FY, Borzilleri R, Fairchild CR, Kim SH, Long BH, Reventos-Suarez C, Vite GD, Rose WC, Kramer RA (2001) BMS-247550 a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy. Clin Cancer Res 7:1429-1437 (Pubitemid 32708699)
-
(2001)
Clinical Cancer Research
, vol.7
, Issue.5
, pp. 1429-1437
-
-
Lee, F.Y.F.1
Borzilleri, R.2
Fairchild, C.R.3
Kim, S.-H.4
Long, B.H.5
Reventos-Suarez, C.6
Vite, G.D.7
Rose, W.C.8
Kramer, R.A.9
-
11
-
-
0036606778
-
2-Aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors
-
Beckers T, Reissmann T, Schmidt M, Burger AM, Fiebig HH, Vanhoefer U, Pongratz H, Hufsky H, Hockemeyer J, Frieser M, Mahboobi S (2002) 2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors. Cancer Res 62:3113-3119 (Pubitemid 34602403)
-
(2002)
Cancer Research
, vol.62
, Issue.11
, pp. 3113-3119
-
-
Beckers, T.1
Reissmann, T.2
Schmidt, M.3
Burger, A.M.4
Fiebig, H.H.5
Vanhoefer, U.6
Pongratz, H.7
Hufsky, H.8
Hockemeyer, J.9
Frieser, M.10
Mahboobi, S.11
-
12
-
-
0032416734
-
Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel
-
DOI 10.1073/pnas.95.26.15798
-
Chou TC, Zhang XG, Harris CR, Kuduk SD, Balog A, Savin KA, Bertino JR, Danishefsky SJ (1998) Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel. Proc Natl Acad Sci USA 95:15798-15802 (Pubitemid 29018780)
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.26
, pp. 15798-15802
-
-
Chou, T.-C.1
Zhang, X.-G.2
Harris, C.R.3
Kuduk, S.D.4
Balog, A.5
Savin, K.A.6
Bertino, J.R.7
Danishefsky, S.J.8
-
13
-
-
0030758777
-
Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization
-
DOI 10.1074/jbc.272.27.17118
-
Giannakakou P, Sackett DL, Kang YK, Zhan Z, Buters JT, Fojo T, Poruchynsky MS (1997) Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization. J Biol Chem 272:17118-17125 (Pubitemid 27289821)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.27
, pp. 17118-17125
-
-
Giannakakou, P.1
Sackett, D.L.2
Kang, Y.-K.3
Zhan, Z.4
Buters, J.T.M.5
Fojo, T.6
Poruchynsky, M.S.7
-
14
-
-
34547153777
-
Mutational analysis of a highly conserved proline residue in MRP1, MRP2, and MRP3 reveals a partially conserved function
-
DOI 10.1124/dmd.107.015479
-
Letourneau IJ, Slot AJ, Deeley RG, Cole SP (2007) Mutational analysis of a highly conserved proline residue in MRP1, MRP2, and MRP3 reveals a partially conserved function. Drug Metab Dispos 35:1372-1379 (Pubitemid 47121778)
-
(2007)
Drug Metabolism and Disposition
, vol.35
, Issue.8
, pp. 1372-1379
-
-
Letourneau, I.J.1
Slot, A.J.2
Deeley, R.G.3
Cole, S.P.C.4
-
15
-
-
0022475690
-
Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones
-
Tsuruo T, Iida-Saito H, Kawabata H, Oh-hara T, Hamada H, Utakoji T (1986) Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones. Jpn J Cancer Res 77:682-692 (Pubitemid 16072385)
-
(1986)
Japanese Journal of Cancer Research
, vol.77
, Issue.7
, pp. 682-692
-
-
Tsuruo, T.1
Iida-Saito, H.2
Kawabata, H.3
-
16
-
-
32344444566
-
Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance
-
DOI 10.1021/jm050800q
-
Fang L, Zhang G, Li C, Zheng X, Zhu L, Xiao JJ, Szakacs G, Nadas J, Chan KK, Wang PG, Sun D (2006) Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance. J Med Chem 49:932-941 (Pubitemid 43221641)
-
(2006)
Journal of Medicinal Chemistry
, vol.49
, Issue.3
, pp. 932-941
-
-
Fang, L.1
Zhang, G.2
Li, C.3
Zheng, X.4
Zhu, L.5
Xiao, J.J.6
Szakacs, G.7
Nadas, J.8
Chan, K.K.9
Wang, P.G.10
Sun, D.11
-
17
-
-
0023392945
-
High-efficiency transformation of mammalian cells by plasmid DNA
-
Chen C, Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752
-
(1987)
Mol. Cell. Biol.
, vol.7
, pp. 2745-2752
-
-
Chen, C.1
Okayama, H.2
-
18
-
-
0347382812
-
Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity
-
DOI 10.1038/sj.bjc.6601370
-
Robey RW, Honjo Y, Morisaki K, Nadjem TA, Runge S, Risbood M, Poruchynsky MS, Bates SE (2003) Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity. Br J Cancer 89:1971-1978 (Pubitemid 37533279)
-
(2003)
British Journal of Cancer
, vol.89
, Issue.10
, pp. 1971-1978
-
-
Robey, R.W.1
Honjo, Y.2
Morisaki, K.3
Nadjem, T.A.4
Runge, S.5
Risbood, M.6
Poruchybsky, M.S.7
Bates, S.E.8
-
19
-
-
0035133804
-
D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity
-
Bacher G, Nickel B, Emig P, Vanhoefer U, Seeber S, Shandra A, Klenner T, Beckers T (2001) D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity. Cancer Res 61:392-399 (Pubitemid 32106651)
-
(2001)
Cancer Research
, vol.61
, Issue.1
, pp. 392-399
-
-
Bacher, G.1
Nickel, B.2
Emig, P.3
Vanhoefer, U.4
Seeber, S.5
Shandra, A.6
Klenner, T.7
Beckers, T.8
-
21
-
-
0037457802
-
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview
-
DOI 10.1016/S0169-409X(02)00169-2, PII S0169409X02001692
-
Schinkel AH, Jonker JW (2003) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 55:3-29 (Pubitemid 36078452)
-
(2003)
Advanced Drug Delivery Reviews
, vol.55
, Issue.1
, pp. 3-29
-
-
Schinkel, A.H.1
Jonker, J.W.2
-
23
-
-
0033452650
-
Induction of apoptosis in MCF-7 cells by indole-3-carbinol is independent of p53 and bax
-
Ge X, Fares FA, Yannai S (1999) Induction of apoptosis in MCF-7 cells by indole-3-carbinol is independent of p53 and bax. Anticancer Res 19:3199-3203 (Pubitemid 30042610)
-
(1999)
Anticancer Research
, vol.19
, Issue.4
, pp. 3199-3203
-
-
Ge, X.1
Fares, F.A.2
Yannai, S.3
-
24
-
-
11844296080
-
Synthesis and cytotoxic activity of 2-acyl-1H-indole-4,7-diones on human cancer cell lines
-
DOI 10.1016/j.ejmech.2004.10.007, PII S0223523404002351
-
Mahboobi S, Sellmer A, Eichhorn E, Beckers T, Fiebig HH, Kelter G (2005) Synthesis and cytotoxic activity of 2-acyl-1H-indole-4,7-diones on human cancer cell lines. Eur J Med Chem 40:85-92 (Pubitemid 40092381)
-
(2005)
European Journal of Medicinal Chemistry
, vol.40
, Issue.1
, pp. 85-92
-
-
Mahboobi, S.1
Sellmer, A.2
Eichhorn, E.3
Beckers, T.4
Fiebig, H.-H.5
Kelter, G.6
-
25
-
-
3042740981
-
BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo
-
Kuo CC, Hsieh HP, Pan WY, Chen CP, Liou JP, Lee SJ, Chang YL, Chen LT, Chen CT, Chang JY (2004) BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo. Cancer Res 64:4621-4628
-
(2004)
Cancer Res.
, vol.64
, pp. 4621-4628
-
-
Kuo, C.C.1
Hsieh, H.P.2
Pan, W.Y.3
Chen, C.P.4
Liou, J.P.5
Lee, S.J.6
Chang, Y.L.7
Chen, L.T.8
Chen, C.T.9
Chang, J.Y.10
-
26
-
-
34548483407
-
4-and 5-aroylindoles as novel classes of potent antitubulin agents
-
Liou JP, Wu CY, Hsieh HP, Chang CY, Chen CM, Kuo CC, Chang JY (2007) 4-and 5-aroylindoles as novel classes of potent antitubulin agents. J Med Chem 50:4548-4552
-
(2007)
J. Med. Chem.
, vol.50
, pp. 4548-4552
-
-
Liou, J.P.1
Wu, C.Y.2
Hsieh, H.P.3
Chang, C.Y.4
Chen, C.M.5
Kuo, C.C.6
Chang, J.Y.7
-
27
-
-
47749140369
-
Discovery of 4-amino and 4-hydroxy-1-aroylindoles as potent tubulin polymerization inhibitors
-
Liou JP, Wu ZY, Kuo CC, Chang CY, Lu PY, Chen CM, Hsieh HP, Chang JY (2008) Discovery of 4-amino and 4-hydroxy-1-aroylindoles as potent tubulin polymerization inhibitors. J Med Chem 51:4351-4355
-
(2008)
J. Med. Chem.
, vol.51
, pp. 4351-4355
-
-
Liou, J.P.1
Wu, Z.Y.2
Kuo, C.C.3
Chang, C.Y.4
Lu, P.Y.5
Chen, C.M.6
Hsieh, H.P.7
Chang, J.Y.8
-
28
-
-
0032143275
-
Tryprostatin A, a specific and novel inhibitor of microtubule assembly
-
Usui T, Kondoh M, Cui CB, Mayumi T, Osada H (1998) Tryprostatin A, a specific and novel inhibitor of microtubule assembly. Biochem J 333 (Pt 3):543-548 (Pubitemid 28398519)
-
(1998)
Biochemical Journal
, vol.333
, Issue.3
, pp. 543-548
-
-
Usui, T.1
Kondoh, M.2
Cui, C.-B.3
Mayumi, T.4
Osada, H.5
-
29
-
-
0035924236
-
Synthetic 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents
-
DOI 10.1021/jm010940+
-
Mahboobi S, Pongratz H, Hufsky H, Hockemeyer J, Frieser M, Lyssenko A, Paper DH, Burgermeister J, Bohmer FD, Fiebig HH et al (2001) Synthetic 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents. J Med Chem 44:4535-4553 (Pubitemid 33144465)
-
(2001)
Journal of Medicinal Chemistry
, vol.44
, Issue.26
, pp. 4535-4553
-
-
Mahboobi, S.1
Pongratz, H.2
Hufsky, H.3
Hockemeyer, J.4
Frieser, M.5
Lyssenko, A.6
Paper, D.H.7
Burgermeister, J.8
Bohmer, F.-D.9
Fiebig, H.-H.10
Burger, A.M.11
Baasner, S.12
Beckers, T.13
-
30
-
-
0031035693
-
Bcl2 is the guardian of microtubule integrity
-
Haldar S, Basu A, Croce CM (1997) Bcl2 is the guardian of microtubule integrity. Cancer Res 57:229-233 (Pubitemid 27038278)
-
(1997)
Cancer Research
, vol.57
, Issue.2
, pp. 229-233
-
-
Haldar, S.1
Basu, A.2
Croce, C.M.3
-
31
-
-
0344420184
-
The mechanism of action of docetaxel (Taxotere) in xenograft models is not limited to bcl-2 phosphorylation
-
DOI 10.1023/A:1025436307913
-
Kraus LA, Samuel SK, Schmid SM, Dykes DJ, Waud WR, Bissery MC (2003) The mechanism of action of docetaxel (Taxotere) in xenograft models is not limited to bcl-2 phosphorylation. Invest New Drugs 21:259-268 (Pubitemid 37486328)
-
(2003)
Investigational New Drugs
, vol.21
, Issue.3
, pp. 259-268
-
-
Kraus, L.A.1
Samuel, S.K.2
Schmid, S.M.3
Dykes, D.J.4
Waud, W.R.5
Bissery, M.C.6
-
32
-
-
58149347705
-
Microtubule active agents: Beyond the taxane frontier
-
Morris PG, Fornier MN (2008) Microtubule active agents: beyond the taxane frontier. Clin Cancer Res 14:7167-7172
-
(2008)
Clin. Cancer Res.
, vol.14
, pp. 7167-7172
-
-
Morris, P.G.1
Fornier, M.N.2
-
33
-
-
26444507974
-
In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models
-
DOI 10.1158/1078-0432.CCR-05-0740
-
Peterson JK, Tucker C, Favours E, Cheshire PJ, Creech J, Billups CA, Smykla R, Lee FY, Houghton PJ (2005) In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models. Clin Cancer Res 11:6950-6958 (Pubitemid 41428753)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.19
, pp. 6950-6958
-
-
Peterson, J.K.1
Tucker, C.2
Favours, E.3
Cheshire, P.J.4
Creech, J.5
Billups, C.A.6
Smykla, R.7
Lee, F.Y.F.8
Houghton, P.J.9
-
34
-
-
0038418500
-
Plant-derived 3,3′-diindolylmethane is a strong androgen antagonist in human prostate cancer cells
-
DOI 10.1074/jbc.M300588200
-
Le HT, Schaldach CM, Firestone GL, Bjeldanes LF (2003) Plantderived 3, 3′-diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J Biol Chem 278:21136-21145 (Pubitemid 36806427)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.23
, pp. 21136-21145
-
-
Le, H.T.1
Schaldach, C.M.2
Firestone, G.L.3
Bjeldanes, L.F.4
|